BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32210538)

  • 1. Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.
    Wang Z; Zang A; Wei Y; An L; Hong D; Shi Y; Zhang J; Su S; Fang G
    Drug Des Devel Ther; 2020; 14():1095-1105. PubMed ID: 32210538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System.
    Qu Z; Ren Y; Shen H; Wang H; Shi L; Tong D
    Drug Des Devel Ther; 2021; 15():3605-3616. PubMed ID: 34447241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
    Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
    Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
    Wang J
    Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy.
    Shao Y; Luo W; Guo Q; Li X; Zhang Q; Li J
    Drug Des Devel Ther; 2019; 13():2043-2055. PubMed ID: 31388296
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers.
    Liu Y; Zhang H; Cui H; Zhang F; Zhao L; Liu Y; Meng Q
    Drug Deliv; 2022 Dec; 29(1):342-350. PubMed ID: 35049388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies.
    Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
    Colloids Surf B Biointerfaces; 2014 Nov; 123():610-5. PubMed ID: 25454755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
    Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of polymeric nanoparticles containing linoleic acid-SN38 (LA-SN38) conjugate in a murine model of colorectal cancer.
    Cheng G; Zhang X; Chen Y; Lee RJ; Wang J; Yao J; Zhang Y; Zhang C; Wang K; Yu B
    Colloids Surf B Biointerfaces; 2019 Sep; 181():822-829. PubMed ID: 31247407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system.
    Qiu L; Dong C; Kan X
    Drug Des Devel Ther; 2018; 12():863-872. PubMed ID: 29713144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers.
    Wang Z; Wei Y; Fang G; Hong D; An L; Jiao T; Shi Y; Zang A
    Drug Des Devel Ther; 2018; 12():3171-3180. PubMed ID: 30288022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation.
    Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
    Colloids Surf B Biointerfaces; 2014 Nov; 123():600-9. PubMed ID: 25454761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy.
    Wang H; Sun G; Zhang Z; Ou Y
    Biomed Pharmacother; 2017 Jul; 91():241-250. PubMed ID: 28460227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.